SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
CardioDx - Bringing molecular diagnostics into the cardiovascular arena
News | 03. 01. 2010
CardioDx
CardioDx is one of several molecular diagnostics companies founded by a well-known trio of West Coast VCs to be fast finding itself in the spotlight.
